Penn Presbyterian Medical Center, in affiliation with the Abramson Cancer Center, has established a remarkable reputation for its exemplary care for mesothelioma patients. Their dedicated Mesothelioma and Pleural Program ensures high-quality, comprehensive treatment options for their patients. The treatment program, which includes the distinguished Harron Lung Center, is handled by a collaborative team of medical experts specializing in lung diseases. The collective effort of this multidisciplinary team enables them to deliver customized treatment plans, suited to the unique needs of each patient, ensuring that they receive the best possible care.
At the heart of the Mesothelioma and Pleural Program at Penn Presbyterian Medical Center is the commitment to offer compassionate and comprehensive care at the highest level. The medical team meets weekly to meticulously discuss each patient’s case, assuring that the treatment plans are on track. Furthermore, the institution provides each patient with a patient navigator, a supportive role that assists with logistics such as answering questions, appointment scheduling, and more. The program does not just focus on clinical expertise but also emphasizes the importance of compassion and understanding in the journey towards healing.
Beyond standard treatment options, Penn Presbyterian Medical Center extends the opportunity for mesothelioma patients to participate in experimental treatments, if eligible. Their association with Penn Medicine enables them to offer various clinical trials, enabling patients to try innovative treatments. The institution’s specializations include mesothelioma, pleural disease, as well as clinical trials and experimental treatments. Through such initiatives, Penn Presbyterian continues to be at the forefront of providing advanced care and innovative treatment options for mesothelioma patients.
Sources:
